Ask AI

Decoding Discoveries in Hematologic Malignancies—Decera Clinical Education's Independent Highlights of the 2026 ASCO and EHA Conferences

Review practice-changing data on the treatment of lymphoma and leukemia from the 2026 ASCO and EHA annual meetings through Capsule Summaries, 2 ClinicalThought commentaries, and a certified expert-authored text module.

For coverage of gastrointestinal, lung, and breast cancers at ASCO 2026, click here.

Share

Program Content

Activities

frontMIND
frontMIND: Phase III Trial of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP for Newly Diagnosed DLBCL
Capsule Summary
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by educational grants from Incyte Corporation, Lilly, and Novartis Pharmaceuticals Corporation.

Incyte Corporation

Lilly

Novartis Pharmaceuticals Corporation